Estonia vs Yemen: HIV/AIDS deaths averted by antiretroviral therapy
Estonia
217.74 deaths
in 2024
Yemen
267.91 deaths
in 2024
Estonia rank
108th
Yemen rank
106th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Estonia
- Yemen
How they compare
Yemen currently reports 267.91 deaths against 217.74 deaths in Estonia, a difference of 50.17 deaths.
That makes Yemen's figure about 1.2 times Estonia's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Yemen ahead.
Estonia ranks 108th and Yemen ranks 106th of 157 countries.
Estonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Estonia | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 76.25 deaths | 10.16 deaths | 66.09 deaths | Estonia |
| 2010s | 296.88 deaths | 127.01 deaths | 169.87 deaths | Estonia |
| 2020s | 240.39 deaths | 218.27 deaths | 22.12 deaths | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Estonia or Yemen?
- Yemen, at 267.91 deaths against 217.74 deaths in Estonia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Estonia and Yemen?
- 50.17 deaths, with Yemen ahead.
- How many years of comparable data are there for Estonia and Yemen?
- 35 years are reported by both, from 1990 to 2024.
- How do Estonia and Yemen rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Estonia ranks 108th and Yemen ranks 106th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.